These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8540714)

  • 1. Once-daily versus twice-daily administration of ceftazidime in the preterm infant.
    van den Anker JN; Schoemaker RC; van der Heijden BJ; Broerse HM; Neijens HJ; de Groot R
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2048-50. PubMed ID: 8540714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftazidime pharmacokinetics in preterm infants: effects of renal function and gestational age.
    van den Anker JN; Schoemaker RC; Hop WC; van der Heijden BJ; Weber A; Sauer PJ; Neijens HJ; de Groot R
    Clin Pharmacol Ther; 1995 Dec; 58(6):650-9. PubMed ID: 8529330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amoxicillin pharmacokinetics in preterm infants with gestational ages of less than 32 weeks.
    Huisman-de Boer JJ; van den Anker JN; Vogel M; Goessens WH; Schoemaker RC; de Groot R
    Antimicrob Agents Chemother; 1995 Feb; 39(2):431-4. PubMed ID: 7726510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infections.
    Benko AS; Cappelletty DM; Kruse JA; Rybak MJ
    Antimicrob Agents Chemother; 1996 Mar; 40(3):691-5. PubMed ID: 8851594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftazidime pharmacokinetics in preterm infants: effect of postnatal age and postnatal exposure to indomethacin.
    van den Anker JN; Hop WC; Schoemaker RC; van der Heijden BJ; Neijens HJ; de Groot R
    Br J Clin Pharmacol; 1995 Nov; 40(5):439-43. PubMed ID: 8703647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of asphyxia on the pharmacokinetics of ceftazidime in the term newborn.
    Van Den Anker JN; Van Der Heijden BJ; Hop WC; Schoemaker RC; Broerse HM; Neijens HJ; De Groot R
    Pediatr Res; 1995 Nov; 38(5):808-11. PubMed ID: 8552453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of intermittent intraperitoneal ceftazidime.
    Grabe DW; Bailie GR; Eisele G; Frye RF
    Am J Kidney Dis; 1999 Jan; 33(1):111-7. PubMed ID: 9915275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of ceftazidime in febrile neutropenic patients.
    Nyhlén A; Ljungberg B; Nilsson-Ehle I
    Scand J Infect Dis; 2001; 33(3):222-6. PubMed ID: 11303815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of ceftazidime in lactating and non-lactating cows.
    Rule R; Quiroga GH; Rubio M; Buschiazzo HO; Buschiazzo PM
    Vet Res Commun; 1996; 20(6):543-50. PubMed ID: 8950835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fundamental and clinical studies on ceftazidime in neonates and premature infants].
    Toyonaga Y; Sugita M; Nakamura H; Kawamura K; Seo K; Takahashi T; Hori M
    Jpn J Antibiot; 1986 Aug; 39(8):2121-41. PubMed ID: 3540345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A pharmacokinetic and clinical evaluation of ceftazidime in neonates and premature infants. A study of ceftazidime in the perinatal co-research group].
    Fujii R; Hashira S; Arimasu O; Fujita K; Murono K; Sakata H; Kakehashi H; Oka T; Kaeriyama M; Yoshioka H
    Jpn J Antibiot; 1986 Aug; 39(8):2048-67. PubMed ID: 3540339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of ceftazidime in loggerhead sea turtles (Caretta caretta) after single intravenous and intramuscular injections.
    Stamper MA; Papich MG; Lewbart GA; May SB; Plummer DD; Stoskopf MK
    J Zoo Wildl Med; 1999 Mar; 30(1):32-5. PubMed ID: 10367641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid ceftazidime kinetics in patients with external ventriculostomies.
    Nau R; Prange HW; Kinzig M; Frank A; Dressel A; Scholz P; Kolenda H; Sörgel F
    Antimicrob Agents Chemother; 1996 Mar; 40(3):763-6. PubMed ID: 8851607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of ceftazidime in serum and peritoneal exudate during continuous versus intermittent administration to patients with severe intra-abdominal infections.
    Buijk SL; Gyssens IC; Mouton JW; Van Vliet A; Verbrugh HA; Bruining HA
    J Antimicrob Chemother; 2002 Jan; 49(1):121-8. PubMed ID: 11751775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fundamental and clinical evaluations of ceftazidime in neonates and premature infants].
    Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita S; Sakata Y; Fujimoto T; Kuda N; Ishimoto K; Tominaga K
    Jpn J Antibiot; 1986 Aug; 39(8):2171-92. PubMed ID: 3540349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis.
    Angus BJ; Smith MD; Suputtamongkol Y; Mattie H; Walsh AL; Wuthiekanun V; Chaowagul W; White NJ
    Br J Clin Pharmacol; 2000 Aug; 50(2):184-91. PubMed ID: 10930972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics, intramuscular bioavailability and tissue residue profiles of ceftazidime in a rabbit model.
    Abd El-Aty AM; Goudah A; Abo El Sooud K
    Dtsch Tierarztl Wochenschr; 2001 Apr; 108(4):168-71. PubMed ID: 11370478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of ceftazidime in serum and suction blister fluid during continuous and intermittent infusions in healthy volunteers.
    Mouton JW; Horrevorts AM; Mulder PG; Prens EP; Michel MF
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2307-11. PubMed ID: 2088186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pharmacokinetics and serum bactericidal activities of SCE-2787 and ceftazidime.
    Paulfeuerborn W; Müller HJ; Borner K; Koeppe P; Lode H
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1835-41. PubMed ID: 8239592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fundamental and clinical evaluation of ceftazidime in neonates and premature infants].
    Sato Y; Iwata S; Kusumoto Y; Shiro H; Oikawa T; Osano M
    Jpn J Antibiot; 1986 Aug; 39(8):2084-96. PubMed ID: 3540342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.